Publications by authors named "Jad Hamze"

Background: Coronary artery disease is the leading cause of death worldwide. It imposes an enormous symptomatic burden on patients, leaving many with residual disease despite optimal procedural therapy and up to one-thirds with debilitating angina amenable neither to procedures, nor to current pharmacological options. Semaglutide (SEM), a GLP-1 (glucagon-like peptide 1) agonist originally approved for management of diabetes, has garnered substantial attention for its capacity to attenuate cardiovascular risk.

View Article and Find Full Text PDF

Objective: Coronary artery disease (CAD) is the leading cause of death worldwide. It imposes an enormous symptomatic burden on patients, leaving many with residual disease despite optimal procedural therapy, and up to 1/3 with debilitating angina amenable neither to procedures, nor to current pharmacologic options. Semaglutide, a glucagon-like peptide 1 agonist originally approved for management of diabetes, has garnered substantial attention for its capacity to attenuate cardiovascular risk.

View Article and Find Full Text PDF
Article Synopsis
  • This project investigates how ChatGPT can improve the readability of patient education materials on interventional radiology (IR) procedures using original texts from the Cardiovascular and Interventional Radiological Society of Europe.
  • It involves calculating various readability scores and simplifying the text to a fifth-grade level, resulting in significant improvements in readability metrics but a decrease in the credibility scores.
  • The study concludes that while ChatGPT effectively makes the material easier to understand, it compromises the reliability of the original text, indicating a need for human oversight in the simplification process.
View Article and Find Full Text PDF